15-/12-lipoxygenase inhibitors (University of California Santa Cruz)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name15-/12-lipoxygenase inhibitors (University of California Santa Cruz)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action12-lipoxygenase inhibitorsArachidonate 15-lipoxygenase inhibitors
TargetsArachidonate 15-lipoxygenase12-lipoxygenase
Therapy Area/IndicationsAtherosclerosisAsthmaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Santa Cruz
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California, Santa Cruz
Active IndicationsN/A
Inactive IndicationsAtherosclerosisAsthmaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A